Skip to main content
Log in

Comparison of antibacterial and antibiofilm activities of biologically synthesized silver nanoparticles against several bacterial strains of medical interest

  • Original Article
  • Published:
Energy, Ecology and Environment Aims and scope Submit manuscript

Abstract

Biological routes have been extensively explored in the synthesis of metallic nanoparticles due to their simplicity and low cost. Among metallic nanoparticles, silver nanoparticles (AgNPs) are widely used in medical applications because of their potent antimicrobial activity. In this work, the ability of the mycelium-free fungus extract produced by Chilean white-root Stereum hirsutum and two plant extracts (green tea and dill) were used in the synthesis of AgNPs. The synthesized nanoparticles were extensively characterized by different techniques. The antibacterial activity of the nanoparticles was demonstrated against the Gram-positive strain Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 3229 (standard CLSI); and the Gram-negative bacterial strains (standard CLSI) Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 13803 and the multidrug-resistant Pseudomonas aeruginosa KPC 37. The values of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were obtained in the range of 1.56–25 µg mL−1. AgNPs synthesized by dill extract showed lower values of MIC and MBC, compared to other nanoparticles. The potent antibiofilm ability of AgNPs was demonstrated, including against the multidrug-resistant P. aeruginosa KPC 37 strain. All synthesized nanoparticles demonstrated antibiofilm activity. AgNPs synthesized by fungus extract demonstrated superior antibiofilm activity, compared to AgNPs synthesized by green tea or dill, at low concentration (1.56 µg mL−1). To our best knowledge, this is the first report to compare the antioxidant and antibacterial effects of AgNPs synthesized by different biological entities (green tea, dill and S. hirsutum) with great importance in the combat of resistant bacteria and biofilms.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

Download references

Acknowledgements

We have appreciated the support from CNPq (404815/2018-9), FAPESP- CONICYTE (2018/08194-2, 2018/02832-7), CONICYT/FONDAP/15130015 and CONICYTE-REDES 180003. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amedea B. Seabra.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rolim, W.R., Lamilla, C., Pieretti, J.C. et al. Comparison of antibacterial and antibiofilm activities of biologically synthesized silver nanoparticles against several bacterial strains of medical interest. Energ. Ecol. Environ. 4, 143–159 (2019). https://doi.org/10.1007/s40974-019-00123-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40974-019-00123-8

Keywords

Navigation